Advertisement

Topics

Drug Development Technology Company Profile

10:31 EST 14th December 2018 | BioPortfolio

Established in 1972, SPG Media PLC is an international business-to-business media company providing world-class controlled circulation magazines, internet reference portals, business conferences and forums.
Our extensive expertise, built through a long history in publishing, has led to an impressive array of products. Our well-respected websites have established themselves as leading sources of information within the industries they serve while our print publications feature editorial content designed to present and analyse cutting edge technology and strategies.
Our mission is to provide senior executives, decision-makers and business communities throughout the world with valued information and services, by communicating industry developments, offering informed opinion and promoting our customers' products and servises

Location

Brunel House55-57 North Wharf Road
London
London
W2 1LA
United Kingdom

Contact

Phone: 44 207 915 9957
Fax: 44 207 915 9958
Email: sundeepmakkar@spgmedia.com


News Articles [3299 Associated News Articles listed on BioPortfolio]

LineaRx signs drug development agreement with Takis

LineaRx, a subsidiary of molecular technology company Applied DNA Sciences, has entered into a joint development agreement with Italian biotech...Read More... The post LineaRx signs drug development a...

Genomics raises $32.5M to develop genetic database technology for drug development

Boston-based drugmaker Vertex Pharmaceuticals leads the round and also enters partnership with UK firm to aid its own drug development efforts.

Will tumor-agnostic drug development help accelerate precision medicine approaches?

The first accelerated approval for a tumor-agnostic drug was granted by the FDA in May 2017, enabling patients with any...Read More... The post Will tumor-agnostic drug development help accelerate pre...

Cancer Research Technology: Driving Cancer Drug Development

In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship bet...

GSK invests $300m in 23andMe under drug development deal

GlaxoSmithKline (GSK) has formed a multi-year alliance with genetics firm 23andMe to carry out research and development for new medicines...Read More... The post GSK invests $300m in 23andMe under dru...

The challenges of EZH2 drug development

EZH2 is an epigenetic protein or chromatin modifier that is frequently overexpressed in cancer and has been implicated in numerous...Read More... The post The challenges of EZH2 drug development appea...

Evox Therapeutics raises new funds to support drug development

UK-based therapeutics developer Evox Therapeutics has secured $45.4m in a series B financing round to support new drug development. The...Read More... The post Evox Therapeutics raises new funds to su...

Halozyme licenses drug-delivery technology to Roche for $25m upfront

Halozyme licensed its drug-delivery technology, Enhanze, to Roche to be used in the development of an undisclosed clinical stage target.

PubMed Articles [4852 Associated PubMed Articles listed on BioPortfolio]

Artificial intelligence in drug development: present status and future prospects.

Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power...

Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology.

Intra-tumor heterogeneity (genotypic and functional diversity among cancer cells within the same tumor) represents one of the key challenges in cancer medicine. As heterogeneity of cancer cells consti...

Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.

The advances in drug delivery technologies have enabled pharmaceutical scientists to deliver a drug through various administration routes and optimize the drug release and absorption. The wide range o...

Controlled release drug delivery systems.

Advanced MALDI mass spectrometry imaging in pharmaceutical research and drug development.

Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) has emerged as a key technology for label-free bioanalysis of the spatial distribution of biomolecules, pharmaceutical...

Clinical Trials [5691 Associated Clinical Trials listed on BioPortfolio]

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

Imaging the Neurochemistry of Drug Addiction With PET

Our project has two overarching goals. 1) We will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse includi...

Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

Background: Drug resistant tuberculosis is a serious public health problem that threatens the health of human life and the development of society and economy. At present, the diagnosis of...

Development of a Screening Strategy for Community-Based Adverse Drug Related Events in the Emergency Department

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting ...

Companies [4508 Associated Companies listed on BioPortfolio]

Receptron Incorporated

Receptron has a novel and proprietary position in drug discovery and development. The company's original focus was on diabetes but now has expanded to include a diverse portfolio of research and devel...

Locum International

The Locum International Group is a limited Research Association comprising of :(a.) A Pharmaceutical Research and Development Company with extensive experience in product development, manufacturing, r...

TransPharma Medical Ltd

stablished in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug del...

Anchor Therapeutics, Inc.

Anchor Therapeutics, Inc. is a leader in the development of pepducin technology. The Company is engaged in the licensing of pepducin technology as research tools for drug developm...

Shimoda Biotech (pty) Ltd

Shimoda Biotech (Proprietary) Limited ("Shimoda") is a leading South African biopharmaceutical discovery company that focuses on the development of innovative, proprietary drug delivery systems and no...

More Information about "Drug Development Technology" on BioPortfolio

We have published hundreds of Drug Development Technology news stories on BioPortfolio along with dozens of Drug Development Technology Clinical Trials and PubMed Articles about Drug Development Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drug Development Technology Companies in our database. You can also find out about relevant Drug Development Technology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record